Literature DB >> 29885941

Simplicity versus complexity: an existential dilemma as risk tools evolve.

Alok A Khorana1.   

Abstract

Mesh:

Year:  2018        PMID: 29885941     DOI: 10.1016/S2352-3026(18)30067-X

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN: 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  5 in total

Review 1.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

2.  Prediction and Prevention of Cancer-Associated Thromboembolism.

Authors:  Alok A Khorana; Maria T DeSancho; Howard Liebman; Rachel Rosovsky; Jean M Connors; Jeffrey Zwicker
Journal:  Oncologist       Date:  2020-12-04

3.  Cancer-associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study.

Authors:  Sarah Sharman Moser; Galia Spectre; Pia Raanani; Orr Friedman-Mazursky; Matanya Tirosh; Gabriel Chodick; Avi Leader
Journal:  Res Pract Thromb Haemost       Date:  2022-05-23

4.  Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.

Authors:  Ryan Pelletier
Journal:  J Oncol Pharm Pract       Date:  2021-03-24       Impact factor: 1.809

Review 5.  Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban.

Authors:  Rupert Bauersachs; Alok A Khorana; Agnes Y Y Lee; Gerald Soff
Journal:  Res Pract Thromb Haemost       Date:  2020-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.